Skip to content

5q35 Microduplication Syndrome C4304526

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition where a small piece of chromosome 5 is duplicated. This can affect development and may cause developmental delays, distinctive facial features, and various health concerns. Treatment focuses on addressing specific symptoms and providing supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Recurrent seizure episodes that may vary in type and severity, requiring neurological evaluation.

Any seizure episode requires immediate medical attention; call emergency services for first-time seizures.

!

Congenital heart defect

Structural heart abnormalities present at birth, which may include septal defects or other cardiac malformations.

Requires immediate pediatric cardiology evaluation; may necessitate surgical intervention.

Global developmental delay

(neurologic)

Delays in reaching developmental milestones such as sitting, walking, and crawling compared to typical children of the same age.

Frequency: 80-90% of patients

Speech and language delay

(neurologic)

Delayed onset of speech and language skills, with difficulties in articulation and expressive language development.

Frequency: 75-85% of patients

Hypotonia

(musculoskeletal)

Reduced muscle tone resulting in floppy limbs and difficulty with motor activities.

Frequency: 70-80% of patients

Facial dysmorphism

(constitutional)

Distinctive facial features including broad forehead, deep-set eyes, and abnormal ear positioning.

Frequency: 80-90% of patients

Growth retardation

(endocrine)

Slowed growth velocity leading to short stature, with weight and height below average percentiles.

Frequency: 50-60% of patients

Renal abnormalities

(genitourinary)

Kidney malformations or urinary tract abnormalities detected through imaging studies.

Frequency: 15-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Growth and Development Tracking

Serial monitoring of growth parameters, developmental milestones, and endocrine function to identify and address growth delays and metabolic complications early.

monitoring
3

Educational Support Services

Individualized education plans and specialized educational interventions addressing learning disabilities, attention deficits, and academic underachievement associated with the condition.

psychological

Additional treatment options

Symptomatic Pharmacotherapy

Targeted medication management for specific symptoms such as attention deficits, anxiety, or behavioral challenges, with careful monitoring for treatment response and side effects.

medication

Family-Based Support Programs

Comprehensive family education and support programs to help caregivers understand the condition, develop appropriate management strategies, and access community resources.

complementary

Corrective Intervention Planning

Surgical assessment for any associated structural abnormalities including facial features, skeletal issues, or other physical manifestations that may benefit from corrective procedures.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 5q35 Microduplication Syndrome C4304526?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Tatton-Brown K, Rahman N. Sotos syndrome. Eur J Hum Genet. 2007;15(3):264-271.

review2007View source →
2

Kurotaki N, Imaizumi K, Harada N, et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet. 2002;30(4):365-366.

review2002View source →
3

Magen MS, Goldstein L, Cubbage J, Lupski JR. Intrachromosomal Duplications: Underappreciated and Highly penetrant. Ann Neurol. 2020;88(1):3-9.

review2020View source →
4

ACMG Board of Directors. Clinical cytogenetics: ACMG 2020 standards and guidelines. Genet Med. 2021;23(5):895-909.

guideline2021View source →
5

Lupski JR. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease phenotypes. Cell. 2007;128(6):1003-1017.

review2007View source →
6

Kelley RI, Robinson D, Punnett HH, et al. A case of 5q35 microduplication. Am J Med Genet A. 2010;152A(4):1026-1031.

7

Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444(7118):444-454.

review2006View source →
8

Stankiewicz P, Lupski JR. Genome architecture, rearrangements and genomic disorders. Trends Genet. 2002;18(2):74-82.

review2002View source →
9

Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749-764.

consensus2010View source →
10

McGhee J, Hamosh A, Valle D, Beaudet AL, Vogel H, editors. Thompson & Thompson: Genetics in Medicine. 8th ed. Elsevier; 2016.

textbook2016View source →

Medication Comparisons

Compare medications used to treat 5q35 Microduplication Syndrome C4304526. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy